|
AU770726B2
(en)
*
|
1998-10-20 |
2004-02-26 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw |
Use of a cytokine-producing lactococcus strain to treat colitis
|
|
AUPQ291499A0
(en)
*
|
1999-09-17 |
1999-10-07 |
Women's And Children's Hospital Adelaide |
Novel nitro and sulphur containing compounds
|
|
NO328803B1
(no)
*
|
2000-03-03 |
2010-05-18 |
Thia Medica |
Nye fettsyreanaloger
|
|
PT1311269E
(pt)
|
2000-08-04 |
2012-05-10 |
Dmi Biosciences Inc |
Método de utilização de dicetopiperazinas e composição que contém as mesmas
|
|
NO20006008L
(no)
*
|
2000-11-28 |
2002-05-29 |
Thia Medica As |
Fettsyreanaloger for behandling av inflammatoriske og autoimmune sykdommer
|
|
US7780961B2
(en)
*
|
2001-05-03 |
2010-08-24 |
Actogenix N.V. |
Self-containing Lactococcus strain
|
|
EP1571970B1
(en)
*
|
2002-10-02 |
2011-08-17 |
DMI Biosciences, Inc. |
Diagnosis and monitoring of diseases
|
|
CA2506031A1
(en)
*
|
2002-11-15 |
2004-06-03 |
Vib Vzw |
Self-containing lactobacillus strain comprising a thya mutation and therapeutic applications thereof
|
|
GB0311081D0
(en)
*
|
2003-05-14 |
2003-06-18 |
Btg Internat Limted |
Treatment of neurodegenerative conditions
|
|
KR20120101164A
(ko)
|
2003-05-15 |
2012-09-12 |
디엠아이 바이오사이언시스, 인크 |
Ｔ-세포 매개성 질환의 치료 방법
|
|
CH698539A8
(de)
*
|
2003-08-18 |
2009-10-15 |
Btg Int Ltd |
Verbindungen mit ungesättigten Fettsäureresten zur Herstellung von Medikamenten zur Behandlung von multipler Sklerose.
|
|
DE10351111A1
(de)
*
|
2003-11-03 |
2005-06-16 |
Langlotz, Rainer |
Arzneimittel und Verfahren zu ihrer Herstellung
|
|
WO2005073164A1
(en)
*
|
2004-01-30 |
2005-08-11 |
Peplin Biolipids Pty Ltd |
Therapeutic and carrier molecules
|
|
US7544714B2
(en)
*
|
2004-07-16 |
2009-06-09 |
University Of Massachusetts |
Lipid-amino acid conjugates and methods of use
|
|
GB0425932D0
(en)
*
|
2004-11-25 |
2004-12-29 |
Btg Int Ltd |
Structured phospholipids
|
|
GB0504362D0
(en)
*
|
2005-03-02 |
2005-04-06 |
Btg Int Ltd |
Cytokine modulators
|
|
GB0504333D0
(en)
*
|
2005-03-02 |
2005-04-06 |
Btg Int Ltd |
Treatment of cytokine dysregulation
|
|
US20060246115A1
(en)
*
|
2005-03-04 |
2006-11-02 |
Ricardo Rueda |
Nutritional products for ameliorating symptoms of rheumatoid arthritis
|
|
EP2119450B1
(en)
|
2005-11-29 |
2013-02-13 |
Actogenix N.V. |
Induction of mucosal tolerance to pancreatic islet beta-cell autoantigens
|
|
EP2125010B1
(en)
|
2007-01-25 |
2014-06-04 |
Actogenix N.V. |
Treatment of immune disease by mucosal delivery of antigens using genetically modified lactobacillus
|
|
EP2120916A4
(en)
*
|
2007-02-05 |
2010-07-28 |
Children Youth And Women S Hea |
MODULATORS FOR THE PROLIFERATION OF T CELLS DEPENDENT OF ANTIGEN
|
|
WO2009061208A1
(en)
|
2007-11-09 |
2009-05-14 |
Pronova Biopharma Norge As |
Lipid compounds for use in cosmetic products, as food supplement or as a medicament
|
|
JP5856843B2
(ja)
|
2008-05-27 |
2016-02-10 |
アンピオ ファーマシューティカルズ，インコーポレイテッド |
ジケトピペラジンを用いた医薬組成物
|
|
EP2147910A1
(en)
|
2008-07-15 |
2010-01-27 |
Pronova BioPharma Norge AS |
Novel lipid compounds
|
|
NZ596386A
(en)
*
|
2009-05-08 |
2014-01-31 |
Pronova Biopharma Norge As |
Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
|
|
GB0909643D0
(en)
|
2009-06-04 |
2009-07-22 |
Avexxin As |
Glomerulonephritis treatment
|
|
GB201014633D0
(en)
*
|
2010-09-02 |
2010-10-13 |
Avexxin As |
Rheumatoid arthritis treatment
|
|
CA2810844C
(en)
|
2010-09-07 |
2017-03-21 |
Dmi Acquisition Corp. |
Diketopiperazine compositions for the treatment of metabolic syndrome and related conditions
|
|
UA111475C2
(uk)
|
2010-11-05 |
2016-05-10 |
Пронова Байофарма Нордж Ас |
Способи лікування із застосуванням ліпідних сполук
|
|
MX2014003856A
(es)
|
2011-10-10 |
2015-01-16 |
Ampio Pharmaceuticals Inc |
Dispositivos medicos implantables con tolerancia inmune incrementada y metodos para hacerlos e implantarlos.
|
|
EP2766029B1
(en)
|
2011-10-10 |
2020-03-25 |
Ampio Pharmaceuticals, Inc. |
Treatment of degenerative joint disease
|
|
SG11201400283RA
(en)
|
2011-10-28 |
2014-03-28 |
Ampio Pharmaceuticals Inc |
Treatment of rhinitis
|
|
GB201205394D0
(en)
|
2012-03-27 |
2012-05-09 |
Adlens Ltd |
Improvements in or relating to deformable non-round membrane assemblies
|
|
KR102125587B1
(ko)
|
2012-03-30 |
2020-06-23 |
지보당 에스아 |
식품 향미 화합물인 n-아실-아미노산 유도체, 이를 함유하는 분말 조성물
|
|
WO2013149008A2
(en)
*
|
2012-03-30 |
2013-10-03 |
Givaudan, S.A. |
Improvements in or relating to organic compounds
|
|
EP2830440B1
(en)
|
2012-03-30 |
2019-03-20 |
Givaudan SA |
N-acyl-aminocyclopropyl carboxylic acids as food flavouring compounds
|
|
US10856563B2
(en)
|
2012-03-30 |
2020-12-08 |
Givaudan S.A. |
N-acyl-amino acid derivatives for improvement of the flavor profile of edible compositions
|
|
BR112014023905B1
(pt)
|
2012-03-30 |
2021-07-13 |
Givaudan Sa |
Composições de sabor e comestíveis compreendendo derivados de metionina n-acilados e bebida calórica e não-calórica
|
|
SG11201405413SA
(en)
|
2012-03-30 |
2014-10-30 |
Givaudan Sa |
N-acyl derivatives of gamma amino - butyric acid and and beta alanine as food flavouring compounds
|
|
CA2867329C
(en)
|
2012-03-30 |
2020-03-10 |
Givaudan S.A. |
N-acylated 1 - aminocycloalkyl carboxylic acids as food flavouring compounds
|
|
CA2868073C
(en)
|
2012-03-30 |
2020-12-29 |
Givaudan S.A. |
N-acyl proline derivatives as food flavouring compounds
|
|
GB201221329D0
(en)
*
|
2012-11-27 |
2013-01-09 |
Avexxin As |
Dermatitis treatment
|
|
WO2014132134A1
(en)
|
2013-02-28 |
2014-09-04 |
Pronova Biopharma Norge As |
A composition comprising a lipid compound, a triglyceride, and a surfactant, and methods of using the same
|
|
AU2014232728B2
(en)
|
2013-03-15 |
2019-02-21 |
Ampio Pharmaceuticals, Inc. |
Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
|
|
CN105592720B
(zh)
|
2013-10-02 |
2020-07-07 |
奇华顿股份有限公司 |
具有味道改进特性的有机化合物
|
|
US10537127B2
(en)
|
2013-10-02 |
2020-01-21 |
Givaudan S.A. |
Organic compounds
|
|
CN105636934B
(zh)
|
2013-10-02 |
2019-03-29 |
奇华顿股份有限公司 |
N-酰化的2-氨基异丁酸化合物和包含它们的香味组合物
|
|
WO2015050535A1
(en)
|
2013-10-02 |
2015-04-09 |
Givaudan S.A. |
Organic compounds
|
|
GB201317424D0
(en)
|
2013-10-02 |
2013-11-13 |
Givaudan Sa |
Improvements in or relating to organic compounds
|
|
CN105592719B
(zh)
|
2013-10-02 |
2020-03-10 |
奇华顿股份有限公司 |
有机化合物
|
|
EP3057448B1
(en)
|
2013-10-02 |
2017-12-06 |
Givaudan S.A. |
Organic compounds having taste-modifying properties
|
|
GB201409363D0
(en)
|
2014-05-27 |
2014-07-09 |
Avexxin As |
Skin cancer treatment
|
|
EP3183240A4
(en)
|
2014-08-18 |
2018-06-27 |
Ampio Pharmaceuticals, Inc. |
Treatment of joint conditions
|
|
KR20240033300A
(ko)
|
2015-04-28 |
2024-03-12 |
바스프 에이에스 |
비알코올성 지방간염의 예방 및/또는 치료를 위한 구조적으로 강화된 함황 지방산의 용도
|
|
US11389512B2
(en)
|
2015-06-22 |
2022-07-19 |
Ampio Pharmaceuticals, Inc. |
Use of low molecular weight fractions of human serum albumin in treating diseases
|
|
US11690825B2
(en)
|
2016-03-09 |
2023-07-04 |
Board Of Regents, The University Of Texas System |
20-HETE receptor (GPR75) antagonists and methods of use
|
|
GB201604316D0
(en)
|
2016-03-14 |
2016-04-27 |
Avexxin As |
Combination therapy
|
|
WO2018055062A1
(en)
|
2016-09-21 |
2018-03-29 |
Avexxin As |
Pharmaceutical composition
|
|
EP3720431B1
(en)
|
2017-12-06 |
2024-10-30 |
Basf As |
Fatty acid derivatives for treating non-alcoholic steatohepatitis
|